Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02291120
Other study ID # UIC-ODP-4
Secondary ID
Status Recruiting
Phase Phase 4
First received June 27, 2014
Last updated November 11, 2014
Start date March 2014
Est. completion date December 2016

Study information

Verified date November 2014
Source Universitat Internacional de Catalunya
Contact n/a
Is FDA regulated No
Health authority Spain: Comité Ético de Investigación Clínica
Study type Interventional

Clinical Trial Summary

The objective of the study is to evaluate and compare, clinically and radiographically,the effects of MEDCEM PC and MTA when used as pulp dressings following pulpotomy in human primary molars.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date December 2016
Est. primary completion date October 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 3 Years to 10 Years
Eligibility Inclusion Criteria:

- healthy children

- molars showing: symptomless exposure of vital pulp by caries no clinical or radiographic evidence of pulp degeneration (excessive bleeding from the root canal, internal root resorption, inter-radicular and/or furcal bone destruction) the possibility of proper restoration of the teeth no physiological resorption of more than one-third of the root

Exclusion Criteria:

- presence of systemic pathology

- history of allergic reaction to latex, local anaesthetics or to the constituents of the test pulp dressing agents

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Evaluate the Effects of MEDCEM PC and MTA in Pulpotomies of Primary Molars.

Intervention

Procedure:
Pulpotomy


Locations

Country Name City State
Spain Universitat Internacional de Catalunya Sant Cugat del Valles Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Universitat Internacional de Catalunya

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical success No pain, no swelling, no fistula or sinus tract, no pathologic mobility 24 months No
Primary Radiographic success No internal root resorption progressing into the bone, no external root resorption, no furcation and/or periapical bone destruction 24 months No